140 related articles for article (PubMed ID: 31695139)
1. Prostate cancer characteristics and cancer-specific mortality of Native American patients.
Deuker M; Knipper S; Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Tian Z; Saad F; Chun F; Karakiewicz PI
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):277-285. PubMed ID: 31695139
[TBL] [Abstract][Full Text] [Related]
2. PSA, stage, grade and prostate cancer specific mortality in Asian American patients relative to Caucasians according to the United States Census Bureau race definitions.
Deuker M; Stolzenbach LF; Pecoraro A; Rosiello G; Luzzago S; Tian Z; Saad F; Chun FK; Karakiewicz PI
World J Urol; 2021 Mar; 39(3):787-796. PubMed ID: 32458094
[TBL] [Abstract][Full Text] [Related]
3. Contemporary Trends and Survival Outcomes After Aborted Radical Prostatectomy in Lymph Node Metastatic Prostate Cancer Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Fossati N; Gandaglia G; Gallina A; Abdollah F; Shariat SF; Montorsi F; Saad F; Tilki D; Briganti A; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):381-388. PubMed ID: 29366856
[TBL] [Abstract][Full Text] [Related]
4. Survival after radical prostatectomy or radiotherapy for locally advanced (cT3) prostate cancer.
Bandini M; Marchioni M; Preisser F; Zaffuto E; Tian Z; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
World J Urol; 2018 Sep; 36(9):1399-1407. PubMed ID: 29717358
[TBL] [Abstract][Full Text] [Related]
5. Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities.
Würnschimmel C; Wenzel M; Collà Ruvolo C; Nocera L; Tian Z; Saad F; Briganti A; Shariat SF; Mandel P; Chun FKH; Tilki D; Graefen M; Karakiewicz PI
World J Urol; 2021 Oct; 39(10):3781-3787. PubMed ID: 33978812
[TBL] [Abstract][Full Text] [Related]
6. External beam radiation therapy improves survival in high- and intermediate-risk non-metastatic octogenarian prostate cancer patients.
Knipper S; Dzyuba-Negrean C; Palumbo C; Pecoraro A; Rosiello G; Tian Z; Briganti A; Saad F; Tilki D; Graefen M; Karakiewicz PI
Int Urol Nephrol; 2020 Jan; 52(1):59-66. PubMed ID: 31542882
[TBL] [Abstract][Full Text] [Related]
7. Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations.
Leyh-Bannurah SR; Karakiewicz PI; Pompe RS; Preisser F; Zaffuto E; Dell'Oglio P; Briganti A; Nafez O; Fisch M; Steuber T; Graefen M; Budäus L
World J Urol; 2019 Mar; 37(3):469-479. PubMed ID: 29992380
[TBL] [Abstract][Full Text] [Related]
8. The effect of age on cancer-specific mortality in patients with prostate cancer: a population-based study across all stages.
Knipper S; Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Deuker M; Tian Z; Shariat SF; Saad F; Tilki D; Graefen M; Karakiewicz PI
Cancer Causes Control; 2020 Mar; 31(3):283-290. PubMed ID: 32034540
[TBL] [Abstract][Full Text] [Related]
9. Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis.
Gandaglia G; Sun M; Trinh QD; Becker A; Schiffmann J; Hu JC; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI; Abdollah F
BJU Int; 2014 Dec; 114(6b):E62-E69. PubMed ID: 24467651
[TBL] [Abstract][Full Text] [Related]
10. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
[TBL] [Abstract][Full Text] [Related]
11. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy.
Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY
Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648
[TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis.
Bandini M; Pompe RS; Marchioni M; Tian Z; Gandaglia G; Fossati N; Tilki D; Graefen M; Montorsi F; Shariat SF; Briganti A; Saad F; Karakiewicz PI
World J Urol; 2018 Jan; 36(1):7-13. PubMed ID: 29063268
[TBL] [Abstract][Full Text] [Related]
13. Local Therapy Improves Survival in Metastatic Prostate Cancer.
Leyh-Bannurah SR; Gazdovich S; Budäus L; Zaffuto E; Briganti A; Abdollah F; Montorsi F; Schiffmann J; Menon M; Shariat SF; Fisch M; Chun F; Steuber T; Huland H; Graefen M; Karakiewicz PI
Eur Urol; 2017 Jul; 72(1):118-124. PubMed ID: 28385454
[TBL] [Abstract][Full Text] [Related]
14. Cancer-specific survival after radical prostatectomy versus external beam radiotherapy in high-risk and very high-risk African American prostate cancer patients.
Hoeh B; Würnschimmel C; Flammia RS; Horlemann B; Sorce G; Chierigo F; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Terrone C; Shariat SF; Kluth LA; Mandel P; Chun FKH; Karakiewicz PI
Prostate; 2022 Jan; 82(1):120-131. PubMed ID: 34662443
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients.
Bandini M; Preisser F; Nazzani S; Marchioni M; Tian Z; Mazzone E; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2018 Aug; 1(3):215-222. PubMed ID: 31102624
[TBL] [Abstract][Full Text] [Related]
16. Differences between rural and urban prostate cancer patients.
Stolzenbach LF; Deuker M; Collà-Ruvolo C; Nocera L; Tian Z; Maurer T; Tilki D; Briganti A; Saad F; Mirone V; Chun FKH; Graefen M; Karakiewicz PI
World J Urol; 2021 Jul; 39(7):2507-2514. PubMed ID: 33155063
[TBL] [Abstract][Full Text] [Related]
17. Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients.
Hoeh B; Hohenhorst JL; Flammia R; Horlemann B; Sorce G; Chierigo F; Tian Z; Saad F; Graefen M; Gallucci M; Briganti A; Terrone C; Shariat SF; Kluth LA; Becker A; Chun FKH; Karakiewicz PI
Int Urol Nephrol; 2022 Jan; 54(1):81-87. PubMed ID: 34783982
[TBL] [Abstract][Full Text] [Related]
18. Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.
Marchioni M; Harmouch SS; Nazzani S; Bandini M; Preisser F; Tian Z; Kapoor A; Cindolo L; Briganti A; Shariat SF; Schips L; Karakiewicz PI
Cancer Epidemiol; 2018 Jun; 54():112-118. PubMed ID: 29715680
[TBL] [Abstract][Full Text] [Related]
19. Competing risk of the specific mortality among Asian-American patients with prostate cancer: a surveillance, epidemiology, and end results analysis.
Wu D; Yang Y; Jiang M; Yao R
BMC Urol; 2022 Mar; 22(1):42. PubMed ID: 35331219
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Mexican-American vs Caucasian prostate cancer active surveillance candidates.
Collà Ruvolo C; Stolzenbach LF; Nocera L; Deuker M; Mistretta FA; Luzzago S; Tian Z; Longo N; Graefen M; Chun FKH; Saad F; Briganti A; De Cobelli O; Mirone V; Karakiewicz PI
Urol Oncol; 2021 Jan; 39(1):74.e1-74.e7. PubMed ID: 32950397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
